Beyond the Sequence: Advancing siRNA Leads for CNS Delivery

• Aerska is developing siRNAs for CNS indications
• Aerska’s lead program is APP Program for the treatment of Alzheimer’s Disease
• Aerska will be presenting their approach in siRNA lead development to identify a potent sequence and the delivery strategy to reach CNS

Speakers:

Duygu Yilmaz

Director, RNA Therapeutics & Translational Science

Aerska